Obesity Commercial Lead (Pre-Launch), ICO

Obesity Commercial Lead (Pre-Launch), ICO

• United States – New York – New York City
• United States – Pennsylvania – Collegeville

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.

ROLE SUMMARY

The Obesity Commercial Lead (s) (Pre-Launch) is a senior, high-impact commercial leadership role accountable for shaping the International pre-launch strategy and setting up Pfizer’s emerging Obesity portfolio for sustained growth across diverse markets. As part of the International Commercial Office (ICO) and in close partnership with US and Country teams, this role defines where to play and how to win—making clear, data and insight-based choices that direct investment, sequencing, and execution priorities across International to build a winning Obesity category. This role will lead with AI and demonstrate the potential of this technology to transform all phases of our launch. As assets progress through late-stage development, the role translates clinical evidence into differentiated value propositions, anticipates competitor and market dynamics, and builds an integrated International commercial strategy. The role is the primary International commercial partner to China for the upcoming GLP‑1 launch, supporting strategy, positioning, launch readiness and execution for Pfizer’s first entry into the Obesity category. The role requires senior-level strategic and transformational leadership, integrating evidence, insights and stakeholder needs into enterprise-aligned recommendations and decisive, prioritised plans. In a highly matrixed environment, the individual demonstrates strong judgement, constructs clear decision narratives, and drives alignment across countries and US/Comm Dev Obesity ensuring that the right decisions are made at the right time. The role leads cross‑functional integration across Marketing, Sales, Access, Medical, Supply and Operations to convert strategy into executable winning plans. This role is one of four critical leadership positions in ICO responsible for ensuring Pfizer’s Obesity assets enter International markets with clear differentiation, strategic coherence, and executional readiness. All responsibilities are executed in accordance with Pfizer policies on pre‑launch and pre‑approval and communication guidance.

ROLE RESPONSIBILITIES

• Lead development of International pre‑launch internal marketing and brand strategy frameworks, focused on disease awareness, market development, and launch readiness.
• Champion a patient mindset by building deep insight into unmet need, motivations, barriers to adoption and persistence, and the end‑to‑end treatment experience; embed these insights into positioning, messaging, and journey design.
• Use integrated competitive intelligence, market research, real‑world insights and KOL/customer input to drive decision quality and sharpen differentiation across International markets.
• Assess market potential and headroom for growth of new brands to accelerate launch uptake across International, defining where to play and the implications for sequencing and resourcing.
• Define customer segmentation and targeting across stakeholder groups (patient self‑pay, HCP, payer/access, policy), ensuring strategy and execution reflect local market realities while remaining globally coherent.
• Lead development of foundational International brand strategic frameworks, including channel and content strategy, investment/spend guidance and internal governance for HCP and patient engagement, with Medical Affairs owning scientific exchange and external content delivery during pre‑approval phases.
• Develop scenario‑based analyses to inform International decisions on launch readiness, prioritisation, and investment trade‑offs; explicitly articulate assumptions, risks, and triggers for course‑correction.
• Lead strategic integration across Commercial, Medical, Access, Supply, Policy and Operations to ensure launch strategies are coherent, feasible, and set up to win in market.
• Act as a senior strategic advisor to International leadership during pre‑launch and early launch phases to support investment decisions and cross‑portfolio resource trade‑offs, maintaining focus on mid/long‑term International value.
• Role model enterprise leadership, collaboration, and long‑term value creation; drive alignment through clear decision narratives and governance‑ready recommendations.
• Lead initiatives to solve for International opportunities and challenges related to manufacturing/inventory allocation, IP, regulatory, pricing, legal, political, access and affordability, tender and contracting.
• Communicate complex strategic topics with clarity and credibility to senior stakeholders across diverse geographies, influence decisions and outcomes without direct authority.
• Create and sustain a team culture that values high performance, patient centric innovation, learning agility, and constructive challenge to the status quo.

BASIC QUALIFICATIONS

• Bachelor’s degree with significant pharmaceutical industry experience in one or more of the following disciplines: Commercial Development, Marketing, Strategy, New product launch, new business assessment or Analytics. MBA preferred.
• 12 years of relevant experience with significant commercial leadership experience shaping and executing pre‑launch strategy. Deep understanding of clinical, access, and policy dynamics. Obesity/cardiometabolic experience preferred.
• Strong analytical rigor, strategic and enterprise mindset, and commercial acumen. Demonstrated expertise in assessing market trends, competitive landscapes, and identifying growth opportunities. Demonstrated ability to make high‑quality, choiceful recommendations (prioritisation and trade‑offs) and translate them into executable plans.
• Track record of applying deep patient insight to shape positioning, messaging, channel strategy and experience/journey design (including adherence and persistence drivers), ideally within complex, multi‑stakeholder healthcare markets.
• Senior Level executive presence and emotional intelligence, with a track record of influencing beyond direct areas of accountability. Exceptional stakeholder management skills, influence and align cross‑functional and cross‑regional teams in a matrixed environment. Capacity to champion new ideas and influence strategic direction through impact and thought leadership.
• Proficient in leveraging artificial intelligence tools and technologies to drive commercial insights, optimise decision‑making and support innovation. Able to navigate emerging AI trends and integrate them effectively into strategic business processes and execution.
• Excellent communication skills, able to translate complex insights into clear strategic recommendations.
• Highly motivated, proactive, and adaptable. Demonstrates integrity, resilience, and a commitment to continuous improvement.

ORGANIZATIONAL RELATIONSHIPS

A key partner to US and Comm Dev leaders, representing International markets, along with International countries and the wider cross‑functional team who will all contribute to our success.

SUPERVISION

Direct reports will be added to these roles as the pre‑launch team is built. It is anticipated that each lead will manage a team of Marketing colleagues for their specific area.

Last Day to Apply: May 15, 2026

Location: Selected candidate must be onsite 2.5/weekly.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E‑Verify employer. This position requires permanent work authorization in the United States.